ISIN | LU1280185148 |
---|---|
Valor Number | 29323863 |
Bloomberg Global ID | |
Fund Name | MFS Meridian Funds - Global Equity Income Fund AH1 Acc |
Fund Provider |
MFS International Limited
London, United Kingdom Phone: +44 20 7429 7200 |
Fund Provider | MFS International Limited |
Representative in Switzerland |
Reyl & Cie S.A. Genève Phone: +41 22 816 80 00 |
Distributor(s) |
Carnegie Fund Services S.A. Genève 11 Phone: +41 22 705 11 77 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The Fund’s investment objective is to seek total return through a combination of current income and capital appreciation, measured in US dollars. The Fund invests primarily (at least 70%) in equity securities of companies located in developed and emerging market countries. The Fund normally primarily invests in income-producing equity securities. The Fund invests the majority of its assets in dividend-paying common stocks, but may invest in other types of income producing securities, including convertible securities, preferred stocks and equity interests in closed-ended real estate investment trusts (REITs) or equity securities of companies principally engaged in the real estate industry. The Fund may also invest in non-income-producing equity securities. |
Peculiarities |
Current Price * | 16.69 EUR | 16.09.2025 |
---|---|---|
Previous Price * | 16.70 EUR | 15.09.2025 |
52 Week High * | 16.82 EUR | 11.09.2025 |
52 Week Low * | 13.89 EUR | 08.04.2025 |
NAV * | 16.69 EUR | 16.09.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 9,333,098 | |
Unit/Share Assets *** | 334,178 | |
Trading Information SIX |
YTD Performance | +10.97% |
31.12.2024 - 16.09.2025
31.12.2024 16.09.2025 |
---|---|---|
YTD Performance (in CHF) | +10.35% |
31.12.2024 - 16.09.2025
31.12.2024 16.09.2025 |
1 month | +1.34% |
18.08.2025 - 16.09.2025
18.08.2025 16.09.2025 |
3 months | +4.51% |
16.06.2025 - 16.09.2025
16.06.2025 16.09.2025 |
6 months | +5.77% |
17.03.2025 - 16.09.2025
17.03.2025 16.09.2025 |
1 year | +4.31% |
16.09.2024 - 16.09.2025
16.09.2024 16.09.2025 |
2 years | +21.74% |
18.09.2023 - 16.09.2025
18.09.2023 16.09.2025 |
3 years | +29.78% |
16.09.2022 - 16.09.2025
16.09.2022 16.09.2025 |
5 years | +48.49% |
16.09.2020 - 16.09.2025
16.09.2020 16.09.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
AbbVie Inc | 3.20% | |
---|---|---|
Roche Holding AG | 2.88% | |
KDDI Corp | 2.87% | |
Colgate-Palmolive Co | 2.59% | |
Kimberly-Clark Corp | 2.57% | |
Tesco PLC | 2.44% | |
Northern Trust Corp | 2.38% | |
Pfizer Inc | 2.31% | |
British American Tobacco PLC | 2.10% | |
Compagnie de Saint-Gobain SA | 2.06% | |
Last data update | 31.08.2025 |
TER *** | 1.70% |
---|---|
TER date *** | 31.01.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.70% |
Ongoing Charges *** | 1.70% |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |